# Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/fsmex for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Fidelity · Asset class: Equity - Strategy: Thematic · Inception: 1998-04-28 This fund typically commits a minimum of 80% of its capital to the securities of companies predominantly involved in the medical technology industry. This includes firms engaged in the research, development, manufacturing, distribution, or sale of medical equipment and related technologies, as well as those supporting drug discovery, and companies providing information technology services primarily to healthcare providers. Its holdings largely consist of common stocks, and it invests in both domestic and international issuers. This is designated as a non-diversified fund. ## Key Facts | Metric | Value | |---|---| | Price | $57.51 | | Expense Ratio | 0.62% | | Assets Under Management | $3.56B | | NAV | $57.51 | | Holdings Count | — | | Distribution Yield (TTM) | 16.57% | | Annual Distribution (TTM) | $9.53 /share | | Distribution Frequency | Semi-Annual | | 52-Week Range | $40.40 – $65.58 | | Beta | 0.81 | ## Latest Distribution - Amount: $6.5420 /share - Ex-date: 2026-04-10 - Pay date: 2026-04-13 ## Frequently Asked Questions ### What does FSMEX invest in? This fund typically commits a minimum of 80% of its capital to the securities of companies predominantly involved in the medical technology industry. This includes firms engaged in the research, development, manufacturing, distribution, or sale of medical equipment and related technologies, as well as those supporting drug discovery, and companies providing information technology services primarily to healthcare providers. Its holdings largely consist of common stocks, and it invests in both domestic and international issuers. This is designated as a non-diversified fund. ### What is the expense ratio of FSMEX? Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) charges an expense ratio of 0.62%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is FSMEX? Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) manages $3.56B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is FSMEX actively managed or an index fund? FSMEX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was FSMEX launched? Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) launched in April 1998 and is managed by Fidelity. ### How has FSMEX performed? FSMEX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does FSMEX pay a dividend? Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) currently distributes little or no income. Trailing-twelve-month yield is 16.57%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does FSMEX pay dividends? Fidelity Select Portfolios - Medical Technology and Devices Portfolio pays dividends Semi-Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is FSMEX's dividend yield? FSMEX's trailing-twelve-month yield is 16.57%, calculated from the sum of dividends over the past year divided by the current price. ### When is FSMEX's next ex-dividend date? The most recently announced ex-dividend date for FSMEX was 2026-04-10. The next ex-date typically follows Semi-Annual; once announced it appears at the top of the dividend history table on this page. ### How much will FSMEX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.62% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does FSMEX charge its expense ratio? The expense ratio is deducted in tiny daily slices from FSMEX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does FSMEX cost more than a fund like VOO? FSMEX's strategy (current expense ratio 0.62%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where FSMEX sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to FSMEX? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as FSMEX (0.62%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/fsmex - Distribution history: https://www.dividenddata.com/funds/fsmex/dividend - Holdings & diversification: https://www.dividenddata.com/funds/fsmex/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/fsmex/expenses - Peer comparison: https://www.dividenddata.com/funds/fsmex/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.